The most common adverse reactions in patients treated with KYNAMRO that led to treatment discontinuation and occurred at a rate greater than placebo were: injection site reactions (5.0%), alanine aminotransferase (ALT) increased (3.4%), flu-like symptoms (2.7%), aspartate aminotransferase (AST) increased (2.3%), and liver function test abnormal (1.5%).

FORBES: FDA Approves Mipomersen For Homozygous Familial Hypercholesterolemia

The Federal Reserve's decision on September 29th to lower its main short-term interest rate by a quarter point is simply an injection of Vitamin B-12, meant to give a healthy economy a bit more vigour.

ECONOMIST: Face value

It is understood there has been a higher rate of fever in young children following a second injection.

BBC: Change to swine flu jab advice